12:00 AM
Nov 12, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

CombiMatrix, Pathology Inc. sales and marketing update

CombiMatrix granted Pathology exclusive rights to market CombiMatrix chromosomal microarray tests to test products of conception to determine if a miscarriage was caused by a chromosomal...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >